JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB54573

Anti-Cystathionase/CTH antibody [2E12-1C10]

Be the first to review this product! Submit a review

|

(11 Publications)

Knockout Tested Mouse Monoclonal Cystathionase/CTH antibody. Suitable for Flow Cyt, WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 11 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human Cystathionine gamma-lyase.

View Alternative Names

Cystathionine gamma-lyase, CGL, CSE, Cysteine desulfhydrase, Cysteine-protein sulfhydrase, Gamma-cystathionase, Homocysteine desulfhydrase, CTH

5 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)

Cystathionase/CTH antibody (ab54573) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human colon.

This image was generated using the ascites version of the product.

Immunocytochemistry/ Immunofluorescence - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)

ICC/IF image of ab54573 stained MCF7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab54573, 5μg/ml) overnight at +4°C. The secondary antibody (green) was ab96879, DyLight® 488 goat anti-mouse IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.
This image was generated using the ascites version of the product.

Flow Cytometry - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)

Overlay histogram showing K562 cells stained with ab54573 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab54573, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in K562 cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

This image was generated using the ascites version of the product.

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)
  • WB

Lab

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)

Western blot : Anti-CTH antibody [2E12-1C10] (ab54573) staining at 1/1000 dilution, shown in green; Rabbit anti-ACTN4 [EPR2533(2)] (ab108198) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab54573 was shown to bind specifically to CTH. A band was observed at 42 kDa in wild-type A549 cell lysates with no signal observed at this size in CTH knockout cell line. To generate this image, wild-type and CTH knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution.

All lanes:

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (ab54573) at 1/1000 dilution

Lane 1:

Wild-type A549 cell lysate at 20 µg

Lane 2:

CTH knockout A549 cell lysate at 20 µg

Lane 3:

K562 cell lysate at 20 µg

Lane 4:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Goat anti-Mouse IgG H&L 800CW and Goat anti-Rabbit IgG H&L 680RD at 1/20000 dilution

Predicted band size: 45 kDa

Observed band size: 42 kDa

false

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)
  • WB

Unknown

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (AB54573)

Cystathionase/CTH antibody (ab54573) at 1ug/lane + K-562 cell lysate at 25ug/lane.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-Cystathionase/CTH antibody [2E12-1C10] (ab54573)

Predicted band size: 45 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

2E12-1C10

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Human

Applications

ICC/IF, Flow Cyt, WB, IHC-P

applications

Immunogen

Recombinant Full Length Protein corresponding to Human Cystathionine gamma-lyase.

P32929

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" } } }

Product details

This product was changed from ascites to tissue culture supernatant on 12/3/19. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.4
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes the last step in the trans-sulfuration pathway from L-methionine to L-cysteine in a pyridoxal-5'-phosphate (PLP)-dependent manner, which consists on cleaving the L,L-cystathionine molecule into L-cysteine, ammonia and 2-oxobutanoate (PubMed : 10212249, PubMed : 18476726, PubMed : 19261609, PubMed : 19961860). Part of the L-cysteine derived from the trans-sulfuration pathway is utilized for biosynthesis of the ubiquitous antioxidant glutathione (PubMed : 18476726). Besides its role in the conversion of L-cystathionine into L-cysteine, it utilizes L-cysteine and L-homocysteine as substrates (at much lower rates than L,L-cystathionine) to produce the endogenous gaseous signaling molecule hydrogen sulfide (H2S) (PubMed : 10212249, PubMed : 19019829, PubMed : 19261609, PubMed : 19961860). In vitro, it converts two L-cysteine molecules into lanthionine and H2S, also two L-homocysteine molecules to homolanthionine and H2S, which can be particularly relevant under conditions of severe hyperhomocysteinemia (which is a risk factor for cardiovascular disease, diabetes, and Alzheimer's disease) (PubMed : 19261609). Lanthionine and homolanthionine are structural homologs of L,L-cystathionine that differ by the absence or presence of an extra methylene group, respectively (PubMed : 19261609). Acts as a cysteine-protein sulfhydrase by mediating sulfhydration of target proteins : sulfhydration consists of converting -SH groups into -SSH on specific cysteine residues of target proteins such as GAPDH, PTPN1 and NF-kappa-B subunit RELA, thereby regulating their function (PubMed : 22169477). By generating the gasotransmitter H2S, it participates in a number of physiological processes such as vasodilation, bone protection, and inflammation (Probable) (PubMed : 29254196). Plays an essential role in myogenesis by contributing to the biogenesis of H2S in skeletal muscle tissue (By similarity). Can also accept homoserine as substrate (By similarity). Catalyzes the elimination of selenocystathionine (which can be derived from the diet) to yield selenocysteine, ammonia and 2-oxobutanoate (By similarity).
See full target information Cystathionine gamma-lyase

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Nature cancer 3:471-485 PubMed35484422

2022

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hamed Alborzinia,Andrés F Flórez,Sina Kreth,Lena M Brückner,Umut Yildiz,Moritz Gartlgruber,Dorett I Odoni,Gernot Poschet,Karolina Garbowicz,Chunxuan Shao,Corinna Klein,Jasmin Meier,Petra Zeisberger,Michal Nadler-Holly,Matthias Ziehm,Franziska Paul,Jürgen Burhenne,Emma Bell,Marjan Shaikhkarami,Roberto Würth,Sabine A Stainczyk,Elisa M Wecht,Jochen Kreth,Michael Büttner,Naveed Ishaque,Matthias Schlesner,Barbara Nicke,Carlo Stresemann,María Llamazares-Prada,Jan H Reiling,Matthias Fischer,Ido Amit,Matthias Selbach,Carl Herrmann,Stefan Wölfl,Kai-Oliver Henrich,Thomas Höfer,Andreas Trumpp,Frank Westermann

Antioxidants (Basel, Switzerland) 11: PubMed35453313

2022

Reduced Levels of HS in Diabetes-Associated Osteoarthritis Are Linked to Hyperglycaemia, Nrf-2/HO-1 Signalling Downregulation and Chondrocyte Dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

María Piñeiro-Ramil,Elena F Burguera,Tamara Hermida-Gómez,Beatriz Caramés,Natividad Oreiro-Villar,Rosa Meijide-Faílde,Francisco J Blanco,Carlos Vaamonde-García

Medical science monitor : international medical journal of experimental and clinical research 27:e929389 PubMed33714972

2021

Association of Hydrogen Sulfide with Femoral Bone Mineral Density in Osteoporosis Patients: A Preliminary Study.

Applications

Unspecified application

Species

Unspecified reactive species

Yan-Ming Hao,Da-Wei He,Yan Gao,Ling-Na Fang,Pan-Pan Zhang,Ke Lu,Rong-Zhu Lu,Chong Li

Journal of advanced research 27:177-190 PubMed33318876

2020

Targeting hydrogen sulphide signaling in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Rana Ahmed Youness,Ahmed Zakaria Gad,Khaled Sanber,Yong Jin Ahn,Gi-Ja Lee,Emad Khallaf,Hafez Mohamed Hafez,Amira Abdel Motaal,Nabil Ahmed,Mohamed Zakaria Gad

Helicobacter 25:e12732 PubMed32713122

2020

Helicobacter pylori infection modulates endogenous hydrogen sulfide production in gastric cancer AGS cells.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshinari Kawahara,Yuka Hirashita,Chikako Tamura,Yoko Kudo,Kumiko Sakai,Kazumi Togo,Kensuke Fukuda,Osamu Matsunari,Kazuhisa Okamoto,Ryo Ogawa,Kazuhiro Mizukami,Tadayoshi Okimoto,Masaaki Kodama,Kazunari Murakami

International journal of biometeorology 64:997-1010 PubMed31734816

2019

Hydrogen sulfide biosynthesis is impaired in the osteoarthritic joint.

Applications

Unspecified application

Species

Unspecified reactive species

Elena F Burguera,Ángela Vela-Anero,Lucía Gato-Calvo,Carlos Vaamonde-García,Rosa Meijide-Faílde,Francisco J Blanco

Oncology reports 41:427-436 PubMed30365149

2018

I157172, a novel inhibitor of cystathionine γ-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3.

Applications

Unspecified application

Species

Unspecified reactive species

Lupeng Wang,Haimei Shi,Xiaoyu Zhang,Xiuli Zhang,Ya Liu,Wenyi Kang,Xiaoyan Shi,Tianxiao Wang

Anticancer research 38:3843-3852 PubMed29970504

2018

Hydrogen Sulfide Is Increased in Oral Squamous Cell Carcinoma Compared to Adjacent Benign Oral Mucosae.

Applications

Unspecified application

Species

Unspecified reactive species

Andrew T Meram,Jie Chen,Stavan Patel,Dongsoo D Kim,Brett Shirley,Paul Covello,Domenico Coppola,Eric X Wei,Ghali Ghali,Christopher G Kevil,Rodney E Shackelford

Nitric oxide : biology and chemistry 41:138-45 PubMed24637018

2014

Effect of feeding a high fat diet on hydrogen sulfide (H2S) metabolism in the mouse.

Applications

WB

Species

Mouse

Meng Teng Peh,Azzahra Binti Anwar,David S W Ng,Mohamed Shirhan Bin Mohamed Atan,Srinivasan Dinesh Kumar,Philip K Moore

Science signaling 4:ra86 PubMed22169477

2011

H2S-Induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response.

Applications

WB

Species

Human

Navasona Krishnan,Cexiong Fu,Darryl J Pappin,Nicholas K Tonks
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com